Localization of epitopes for monoclonal antibodies to urokinase‐type plasminogen activator

作者: Helle H. Petersen , Martin Hansen , Susanne L. Schousboe , Peter A. Andreasen

DOI: 10.1046/J.1432-1327.2001.02365.X

关键词:

摘要: 1We localized the epitopes for several murine mAbs to human urokinase-type plasminogen activator (uPA) by Ala scanning mutagenesis and related localization effects of on molecular interactions uPA. Several antibodies against serine proteinase domain (SPD) were found have overlapping composed variable combinations Arg178, Arg179, His180, Arg181, Tyr209, Lys211, Asp214 in so-called 37-loop 60-loop, located near active site taking part binding uPA inhibitor-1 (PAI-1). Besides inhibiting uPA-catalysed activation, all SPD strongly delayed PAI-1, decreasing second-order rate constant 15- 6500-fold. There was no correlation between relative 60-loop substitutions antibodies, indicating that did not delay complex formation blocking residues specific importance uPA–PAI-1 reaction, but rather steric hindrance access PAI-1 site. The affinity only slightly lower than free uPA, are exposed complex. two kringle included Arg108, Arg109, Arg110. ability these block polyanions correlated with a reduced uPA–polyanion after substitution three Arg residues.

参考文章(56)
L. Ding, G. S. Coombs, L. Strandberg, M. Navre, D. R. Corey, E. L. Madison, Origins of the specificity of tissue-type plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 7627- 7631 ,(1995) , 10.1073/PNAS.92.17.7627
Edwin L. Madison, Elizabeth J. Goldsmith, Robert D. Gerard, Mary-Jane H. Gething, Joseph F. Sambrook, Serpin-resistant mutants of human tissue-type plasminogen activator. Nature. ,vol. 339, pp. 721- 724 ,(1989) , 10.1038/339721A0
Glen Spraggon, Christopher Phillips, Ursula K Nowak, Christopher P Ponting, Derek Saunders, Christopher M Dobson, David I Stuart, E.Yvonne Jones, The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure. ,vol. 3, pp. 681- 691 ,(1995) , 10.1016/S0969-2126(01)00203-9
Kathleen Aertgeerts, Camiel J. De Ranter, Nuala A. Booth, Paul J. Declerck, Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases. Journal of Structural Biology. ,vol. 118, pp. 236- 242 ,(1997) , 10.1006/JSBI.1997.3860
Marja van Meijer, Yvonne Roelofs, Jaap Neels, Anton J. G. Horrevoets, Anton-Jan van Zonneveld, Hans Pannekoek, Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator. Journal of Biological Chemistry. ,vol. 271, pp. 7423- 7428 ,(1996) , 10.1074/JBC.271.13.7423
Malgorzata Wilczynska, Ming Fa, Jan Karolin, Per-Ingvar Ohlsson, Lennart B-Å. Johansson, Tor Ny, Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nature Structural & Molecular Biology. ,vol. 4, pp. 354- 357 ,(1997) , 10.1038/NSB0597-354
Daniel A. Lawrence, David Ginsburg, Duane E. Day, Mitchell B. Berkenpas, Ingrid M. Verhamme, Jan-Olov Kvassman, Joseph D. Shore, Serpin-Protease Complexes Are Trapped as Stable Acyl-Enzyme Intermediates Journal of Biological Chemistry. ,vol. 270, pp. 25309- 25312 ,(1995) , 10.1074/JBC.270.43.25309
Lars S. Nielsen, Jan G. Hansen, Lars Skriver, Elaine L. Wilson, Keld Kaltoft, Jesper Zeuthen, Keld Danoe, Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry. ,vol. 21, pp. 6410- 6415 ,(1982) , 10.1021/BI00268A014
Song-Hua Ke, Gary S. Coombs, Kathy Tachias, David R. Corey, Edwin L. Madison, OPTIMAL SUBSITE OCCUPANCY AND DESIGN OF A SELECTIVE INHIBITOR OF UROKINASE Journal of Biological Chemistry. ,vol. 272, pp. 20456- 20462 ,(1997) , 10.1074/JBC.272.33.20456
Peter A. Andreasen, Lars Kjøller, Lise Christensen, Michael J. Duffy, The urokinase-type plasminogen activator system in cancer metastasis: A review International Journal of Cancer. ,vol. 72, pp. 1- 22 ,(1997) , 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z